Payment overview · 2025
General Payments
$485.69
15 reported records · 7 companies
Healthcare provider profile · identity verified
Paul Farid Chebib, MD
Allopathic & Osteopathic Physicians|Internal Medicine · BROWNFIELD, TX · NPI 1730101965
Verified facts
What the public records show
CMS Open Payments records show Paul Farid Chebib, MD received $485.69 in general payments during 2025 across 15 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 57.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Austedo Xr.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 50 claims for Nuedexta by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO as an associated drug or biological on 28 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Austedo by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO XR as an associated drug or biological on 86263 records involving 23643 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Austedo Xr by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $279.86 | 57.6% | 9 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$109.92 | 22.6% | 1 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $24.32 | 5.0% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $24.03 | 5.0% | 1 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $22.10 | 4.5% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $15.72 | 3.2% | 1 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $9.74 | 2.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $262.71 | 13 |
| Education | $222.98 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| SYMPLICITY G3 Normalized: symplicity g3 |
Device | Medtronic, Inc. | $109.92 | 1 | 2025 |
Source payment records
|
|||||
| UZEDY Normalized: uzedy |
Drug | Teva Pharmaceuticals USA, Inc. | $33.77 | 4 | 2025 |
Source payment records
|
|||||
| PURAPLY WOUND MATRIX Normalized: puraply wound matrix |
Device | Organogenesis Inc. | $24.32 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24.03 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $23.11 | 3 | 2025 |
Source payment records
|
|||||
| CAPVAXIVE Normalized: capvaxive |
Biological | Merck Sharp & Dohme LLC | $22.10 | 1 | 2025 |
Source payment records
|
|||||
| GARDASIL 9 Normalized: gardasil 9 |
Biological | Merck Sharp & Dohme LLC | $22.10 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $15.72 | 1 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $9.74 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AUSTEDO XR austedo xr |
2025 | Austedo Xr | 2024 | 31 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
50 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 15 recipient NPIs · example record 1247249192 |
Austedo · 2024 Exact normalized brand match · 1 Part D row |
27 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO XR open payments reported associated product |
CMS Open Payments — General Payments 86263 supporting records · 23643 recipient NPIs · example record 1247244228 |
Austedo Xr · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1654 | 146 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1489 | 167 |
| Gabapentin | Gabapentin | 1141 | 106 |
| Amlodipine Besylate | Amlodipine Besylate | 1035 | 134 |
| Divalproex Sodium | Divalproex Sodium | 1029 | 75 |
| Metformin Hcl | Metformin Hcl | 1014 | 119 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1007 | 169 |
| Lisinopril | Lisinopril | 968 | 120 |
| Furosemide | Furosemide | 948 | 97 |
| Tamsulosin Hcl | Tamsulosin Hcl | 943 | 89 |
| Metoprolol Tartrate | Metoprolol Tartrate | 940 | 75 |
| Trazodone Hcl | Trazodone Hcl | 743 | 57 |
| Montelukast Sodium | Montelukast Sodium | 740 | 97 |
| Buspirone Hcl | Buspirone Hcl | 697 | 58 |
| Klor-Con M20 | Potassium Chloride | 568 | 40 |
| Hydrochlorothiazide | Hydrochlorothiazide | 557 | 70 |
| Potassium Chloride | Potassium Chloride | 501 | 102 |
| Donepezil Hcl | Donepezil Hcl | 477 | 43 |
| Levetiracetam | Levetiracetam | 454 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 447 | 26 |
| Losartan Potassium | Losartan Potassium | 434 | 37 |
| Olanzapine | Olanzapine | 390 | 31 |
| Sertraline Hcl | Sertraline Hcl | 354 | 30 |
| Citalopram Hbr | Citalopram Hydrobromide | 342 | 43 |
| Mirtazapine | Mirtazapine | 324 | 28 |
| Azithromycin | Azithromycin | 311 | 202 |
| Clopidogrel | Clopidogrel Bisulfate | 308 | 61 |
| Jardiance | Empagliflozin | 299 | 33 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 290 | 35 |
| Benztropine Mesylate | Benztropine Mesylate | 279 | 16 |
| Simvastatin | Simvastatin | 276 | 34 |
| Metoprolol Succinate | Metoprolol Succinate | 274 | 45 |
| Memantine Hcl | Memantine Hcl | 270 | 22 |
| Carvedilol | Carvedilol | 261 | 29 |
| Haloperidol | Haloperidol | 259 | suppressed |
| Januvia | Sitagliptin Phosphate | 258 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 251 | 34 |
| Ranolazine Er | Ranolazine | 246 | 14 |
| Gemfibrozil | Gemfibrozil | 229 | suppressed |
| Glipizide | Glipizide | 229 | 20 |
| Omeprazole | Omeprazole | 229 | 26 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 188 | 105 |
| Hydralazine Hcl | Hydralazine Hcl | 186 | 25 |
| Topiramate | Topiramate | 186 | 11 |
| Risperidone | Risperidone | 182 | 19 |
| Baclofen | Baclofen | 181 | suppressed |
| Allopurinol | Allopurinol | 178 | 36 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 178 | suppressed |
| Eliquis | Apixaban | 178 | 27 |
| Niacin Er | Niacin | 177 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 176 | 26 |
| Spironolactone | Spironolactone | 176 | 17 |
| Lamotrigine | Lamotrigine | 168 | 11 |
| Bupropion Xl | Bupropion Hcl | 167 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 163 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 146 | 15 |
| Mounjaro | Tirzepatide | 143 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 138 | 42 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 134 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 130 | 18 |
| Olanzapine Odt | Olanzapine | 121 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 121 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 121 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 119 | 31 |
| Amiodarone Hcl | Amiodarone Hcl | 118 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 112 | 34 |
| Finasteride | Finasteride | 111 | 11 |
| Gemtesa | Vibegron | 111 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 110 | 43 |
| Pentoxifylline | Pentoxifylline | 109 | suppressed |
| Meloxicam | Meloxicam | 105 | 26 |
| Trulicity | Dulaglutide | 105 | 17 |
| Oxcarbazepine | Oxcarbazepine | 103 | 12 |
| Ibuprofen | Ibuprofen | 102 | 38 |
| Fenofibrate | Fenofibrate | 99 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 97 | 22 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 97 | 15 |
| Divalproex Sodium Er | Divalproex Sodium | 90 | suppressed |
| Levofloxacin | Levofloxacin | 87 | 59 |
| Tradjenta | Linagliptin | 84 | suppressed |
| Vascepa | Icosapent Ethyl | 82 | suppressed |
| Torsemide | Torsemide | 81 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 79 | suppressed |
| Sucralfate | Sucralfate | 79 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 78 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 74 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 72 | 14 |
| Lovastatin | Lovastatin | 69 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 68 | suppressed |
| Carbamazepine | Carbamazepine | 67 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 67 | 17 |
| Prazosin Hcl | Prazosin Hcl | 65 | suppressed |
| Atenolol | Atenolol | 64 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 63 | suppressed |
| Cephalexin | Cephalexin | 61 | 49 |
| Chlorthalidone | Chlorthalidone | 60 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 60 | 14 |
| Lactulose | Lactulose | 58 | 20 |
| Tramadol Hcl | Tramadol Hcl | 57 | 26 |
| Tresiba Flextouch U-100 | Insulin Degludec | 56 | 16 |
| Glipizide Er | Glipizide | 55 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 55 | 18 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 54 | suppressed |
| Celecoxib | Celecoxib | 54 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 54 | suppressed |
| Aripiprazole | Aripiprazole | 53 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 52 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 52 | 18 |
| Famotidine | Famotidine | 52 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 52 | 12 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 52 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 51 | suppressed |
| Novolin R | Insulin Regular, Human | 51 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 51 | 23 |
| Amantadine | Amantadine Hcl | 50 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 50 | 21 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 50 | suppressed |
| Phenytoin | Phenytoin | 50 | suppressed |
| Xarelto | Rivaroxaban | 50 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 48 | 35 |
| Etodolac | Etodolac | 48 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 48 | 12 |
| Digoxin | Digoxin | 46 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 45 | 31 |
| Sodium Chloride | 0.9 % Sodium Chloride | 45 | 28 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 44 | suppressed |
| Linzess | Linaclotide | 44 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 44 | 30 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 44 | suppressed |
| Humulin R | Insulin Regular, Human | 43 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 42 | suppressed |
| Calcium Acetate | Calcium Acetate | 39 | suppressed |
| Entresto | Sacubitril/Valsartan | 39 | suppressed |
| Saxagliptin-Metformin Er | Saxagliptin Hcl/Metformin Hcl | 39 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 38 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | suppressed |
| Methylprednisolone | Methylprednisolone | 38 | 34 |
| Trintellix | Vortioxetine Hydrobromide | 38 | suppressed |
| Constulose | Lactulose | 37 | 12 |
| Ingrezza | Valbenazine Tosylate | 37 | suppressed |
| Nystatin | Nystatin | 36 | 11 |
| Paliperidone Er | Paliperidone | 36 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 35 | suppressed |
| Primidone | Primidone | 35 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 34 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 34 | 20 |
| Glimepiride | Glimepiride | 33 | suppressed |
| Levemir Flexpen | Insulin Detemir | 33 | 14 |
| Tiagabine Hcl | Tiagabine Hcl | 32 | suppressed |
| Austedo Xr | Deutetrabenazine | 31 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 31 | suppressed |
| Cilostazol | Cilostazol | 30 | suppressed |
| Glyburide | Glyburide | 30 | suppressed |
| Levofloxacin-D5w | Levofloxacin In Dextrose 5 % | 30 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 30 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 29 | suppressed |
| Novolog | Insulin Aspart | 29 | suppressed |
| Rivastigmine | Rivastigmine | 29 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 28 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 28 | 12 |
| Humalog | Insulin Lispro | 28 | suppressed |
| Austedo | Deutetrabenazine | 27 | suppressed |
| Bumetanide | Bumetanide | 27 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 27 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 27 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 26 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Oxtellar Xr | Oxcarbazepine | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Dutasteride | Dutasteride | 24 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 24 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | 11 |
| Labetalol Hcl | Labetalol Hcl | 23 | suppressed |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 22 | suppressed |
| Ondansetron Odt | Ondansetron | 22 | 21 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 22 | 22 |
| Ozempic | Semaglutide | 22 | suppressed |
| Ramipril | Ramipril | 22 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 22 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 22 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 21 | 16 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 21 | 17 |
| Peg-3350 And Electrolytes | Peg3350/Sod Sulf,bicarb,cl/Kcl | 21 | 21 |
| Pimozide | Pimozide | 21 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 21 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Prednisone | Prednisone | 20 | 12 |
| Lurasidone Hcl | Lurasidone Hcl | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | suppressed |
| Gavilyte-G | Peg3350/Sod Sulf,bicarb,cl/Kcl | 18 | 18 |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 18 | suppressed |
| Lubiprostone | Lubiprostone | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | 11 |
| Vyzulta | Latanoprostene Bunod | 18 | suppressed |
| Levemir | Insulin Detemir | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Nystop | Nystatin | 17 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Febuxostat | Febuxostat | 16 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 16 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 16 | suppressed |
| Secuado | Asenapine | 16 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 16 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 16 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 15 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 14 | 13 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 13 | suppressed |
| Amoxicillin | Amoxicillin | 13 | 11 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 13 | suppressed |
| Latanoprost | Latanoprost | 13 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 12 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Alprazolam | Alprazolam | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Dexilant | Dexlansoprazole | 11 | suppressed |
| Ezetimibe | Ezetimibe | 11 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Kombiglyze Xr | Saxagliptin Hcl/Metformin Hcl | 11 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Zonisamide | Zonisamide | 11 | suppressed |
| Zyprexa Relprevv | Olanzapine Pamoate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $485.69 · 15 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, CAPLYTA, CAPVAXIVE, GARDASIL 9, PURAPLY WOUND MATRIX, REXULTI, SYMPLICITY G3, UZEDY, VOQUEZNA | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Austedo Xr play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error